Superfluid Dx Revenue

Biotechnology Research • United States • 1-10 Employees

Superfluid Dx revenue & valuation

Annual revenue	$855,550
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,800,000
Total funding	No funding

Key Contacts at Superfluid Dx

Bojk Berghuis

Senior Director Of R&D

Gajus Worthington

Chief Executive Officer And Chairman

Company overview

Headquarters	United States
Website	superfluiddx.com
NAICS	541714
Employees	1-10
Socials

Superfluid Dx Email Formats

Superfluid Dx uses 4 email formats. The most common is {first name}{last name} (e.g., johndoe@superfluiddx.com), used 75% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@superfluiddx.com	75%
{first initial}{second initial}{last name}	jodoe@superfluiddx.com	8.3%
{first initial}{last name}	jdoe@superfluiddx.com	8.3%
{last name}{last name}	doedoe@superfluiddx.com	8.3%

About Superfluid Dx

Superfluid is developing the first high-performance, blood-based test for Alzheimer’s Disease (AD) and related dementias off of a platform technology of cell-free mRNA analysis. This next-generation liquid biopsy technology enables non-invasive measurement of the dynamic biology of organs throughout the body, including the brain. Superfluid’s AD diagnostic can assess the underlying biology of disease and detect its presence early, when there is still time to act. Our precise understanding of the underlying pathways of disease enables more specific use of AD therapeutics and treatments which improves patient outcomes, reduces harmful side-effects, and is more cost effective for health systems. Superfluid has a team of experienced inventors, researchers, and operators focused on revolutionizing care for AD including Steve Quake (Stanford Professor and Head of Science at CZI), Gajus Worthington (founder and CEO of Fluidigm), and John Sninsky (Berkeley and CareDX/Celera). Superfluid's underlying approach has been published in peer-reviewed journals. Superfluid is well funded and recently received funding from the National Institute of Aging (NIA) and Alzheimer's Drug Discovery Foundation (ADDF).

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

Superfluid Dx has 6 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Superfluid Dx's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-01-20	4	N/A

Funding Insights

Number of funding rounds

Superfluid Dx Tech Stack

Discover the technologies and tools that power Superfluid Dx's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Cloudflare Bot Management

Security

PWA

Miscellaneous

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

Frequently asked questions

Superfluid Dx is located in US.

Superfluid Dx generates an estimated annual revenue of $855,550. This revenue figure reflects the company's market position and business performance in its industry.

Superfluid Dx has an estimated valuation of $2,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Superfluid Dx has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Superfluid Dx

Bojk Berghuis

Senior Director Of R&D

Gajus Worthington

Chief Executive Officer And Chairman

4.8

40,000 users